Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer

International Journal of Oncology

Volumn 38, Issue 3, 2011, Pages 619-627

  Hoshi, Hirotaka ^a,b   Sawada, Tetsuji ^b   Uchida, Motoyuki ^a   Saito, Hikaru ^a   Iijima, Hiroko ^a   Mikako, Toda Agetsuma ^a   Tsutomu, Wada ^a   Sadaaki, Yamazoe ^b   Hiroaki, Tanaka ^b   Kenjiro, Kimura ^b   Anna, Kakehashi ^b   Min, Wei ^b   Kosei, Hirakawa ^b   Hideki, Wanibuchi ^b  

^a KUREHA CORPORATION   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; MUCIN 5AC; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENICITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, NUDE; MUCIN 5AC; PANCREATIC NEOPLASMS; RNA, SMALL INTERFERING; TUMOR ESCAPE; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952016423     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.911     Document Type: Article

References (35)

1. Carlstedt I, Sheehan JK, Corfield AP and Gallagher JT: Mucus glycoproteins: a gel of a problem. Essays Biochem 20: 40-76, 1985.
2. Bobek LA, Tsai H, Biesbrock AR and Levine MJ: Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem 268: 20563-20569, 1993. (Pubitemid 23278970)
3. Gum JR Jr, Hicks JW, Swallow DM, et al: Molecular cloning of cDNA derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun 171: 407-415, 1990. (Pubitemid 20283222)
4. Gum JR Jr, Hicks JW, Toribara NW, Rothe EM, Lagace RE and Kim YS: The human MUC2 intestinal mucin has cysteinerich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem 267: 21375-21383, 1992.
5. Gum JR Jr, Hicks JW, Toribara NW, Siddiki B and Kim YS: Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem 269: 2440-2446, 1994.
6. Gum JR Jr, Crawley SC, Hicks JW, Szymkowski DE and Kim YS: MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 291: 446-475, 2002.
7. Hollingsworth MA and Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60, 2004. (Pubitemid 38082153)
8. Moniaux N, Nollet S, Porchet N, Degand P, Laine A and Aubert JP: Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J 338: 325-333, 1999.
9. Fauquette V, Aubert S, Groux-Degroote S, Hemon B, Porchet N, van Seuningen I and Pigny P: Transcription factor AP-2 represses both the mucin MUC4 expression and pancreatic cancer cell proliferation. Carcinogenesis 28: 2305-2312, 2007. (Pubitemid 350119564)
10. Porchet N, Pigny P, Buisine MP, Debailleul V, Degand P, Laine A and Aubert JP: Human mucin genes: genomic organization and expression of MUC4, MUC5AC and MUC5B. Biochem Soc Trans 23: 800-805, 1995.
11. Shankar V, Pichan P, Eddy RL Jr, et al: Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol 16: 232-241, 1997. (Pubitemid 127497445)
12. Toribara NW, Roberton AM, Ho SB, et al: Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem 268: 5879-5885, 1993. (Pubitemid 23090922)
13. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR and McGuckin MA: Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 276: 18327-18336, 2001.
14. Yin BW and Lloyd KO: Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem 276: 27371-27375, 2001.
15. Bafna S, Singh AP, Moniaux N, Eudy JD, Meza JL and Batra SK: MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. Cancer Res 68: 9231-9238, 2008.
16. Velcich A, Yang W, Heyer J, et al: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295: 1726-1729, 2002. (Pubitemid 34202910)
17. Balague C, Gambus C, Carrato N, Porchet N, Aubert JP, Kim YS and Real FX: Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology 106: 1054-1061, 1994.
18. Voynow JA, Young LR, Wang Y, Horger T, Rose MC and Fischer BM: Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 276: L835-L843, 1999. (Pubitemid 29249637)
19. Hovenberg HW, Davies JR and Carlstedt I: Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem J 318: 319-324, 1996. (Pubitemid 26283662)
20. Hovenberg HW, Davies JR, Herrmann A, Lindén CJ and Carlstedt I: MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 13: 839-847, 1996. (Pubitemid 26354277)
21. Sheehan JK, Brazeau C, Kutay S, Pigeon H, Kirkham S, Howard M and Thornton DJ: Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem J 347: 37-44, 2000. (Pubitemid 30199038)
22. Janek P, Briand P and Hartman NR: The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res 35: 3698-3704, 1975.
23. Tsutsumida H, Swanson BJ, Singh PK, Caffrey TC, Kitajima S, Goto M, Yonezawa S and Hollingsworth MA: RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin Cancer Res 12: 2976-2987, 2006. (Pubitemid 43837341)
24. Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL and Batra SK: MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 5: 309-320, 2007. (Pubitemid 46706993)
25. Truant S, Bruyneel E, Gouyer V, De Wever O, Pruvot FR, Mareel M and Huet G: Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells. Int J Cancer 104: 683-694, 2003. (Pubitemid 36418504)
26. Ligtenberg MJL, Buijs F, Vos HL and Hilkens J: Suppression of cellular aggregation by high levels of episialin. Cancer Res 52: 2318-2324, 1992.
27. Duan R, Remeijer L, van Dun JM, Osterhaus AD and Verjans GM: Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Inv Ophth Vis Sci 48: 277-284, 2007. (Pubitemid 47251414)
28. Tamamori Y, Sawada T, Nishihara T, et al: Granulocyte-colony stimulating factor enhances chimeric antibody K-MAC5 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils. Int J Oncol 21: 649-654, 2002.
29. Lieschke GJ and Burgess AW: Drug therapy: granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1&2). N Engl J Med 327: 28-35, 99-106, 1992.
30. Stockmeyer B, Valerius T, Repp R, et al: Preclinical studies with FcAγR bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res 57: 696-701, 1997. (Pubitemid 27085653)
31. Hinoda Y, Ikematsu Y, Horinochi M, et al: Increased expression of MUC1 in advanced pancreatic cancer. J Gastroenterol 38: 1162-1166, 2003. (Pubitemid 38128828)
32. Gimmi CD, Morrison BW, Mainprice BA, et al: Brest cancer associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat Med 2: 1367-1370, 1996.
33. Ho JJL: Mucins in the diagnosis and therapy of pancreatic cancer. Curr Pharm Des 6: 1881-1896, 2000.
34. Inaba T, Sano H, Kawahito Y, et al: Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. Proc Natl Acad Sci USA 100: 2736-2741, 2003. (Pubitemid 36297568)
35. Sugihara I, Yoshida M, Shigenobu T, et al: Different progression of tumor xenografts between mucin-producing and mucin-nonproducing mammary adenocarcinoma-bearing mice. Cancer Res 66: 6175-6182, 2006.